Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Johnson and Johnson agrees acquisition of Pulsar Vascular

Johnson and Johnson agrees acquisition of Pulsar Vascular

19th December 2016

Johnson and Johnson has announced that its Codman Neuro business is acquiring the California-based medical technology company Pulsar Vascular.

DePuy Synthes Products, an affiliate of Codman Neuro, will act as the acquiring entity, which will help Codman Neuro to build upon its existing strong position in the neurovascular and neurosurgery market.

Pulsar Vascular is a leading developer of breakthrough platform technology for the neurovascular treatment of complex aneurysms, including the PulseRider system, a minimally-invasive, self-expanding nitinol implant.

This device is used to bridge the neck of cerebral aneurysms during treatment of unruptured wide-neck intracranial aneurysms originating on or near a bifurcation, with its unique saddle shaped-stent leaving minimal metal in the parent artery.

The PulseRider received CE Mark certification in Europe in late 2013, with Codman Neuro acting as exclusive distributor of Pulsar Vascular technology in Europe, the Middle East and Africa.

Shlomi Nachman, chairman of cardiovascular and specialty solutions at Johnson and Johnson's medical devices division, said: "Working together, we will leverage our proven market expertise and strong commercial footprint to bring this technology to many more clinicians worldwide."

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.ADNFCR-8000103-ID-801830177-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.